Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KALV Kalvista Pharmaceuticals Inc

交易中 04-28 14:26:57 EDT

12.96

-0.03

-0.23%

最高13.20	最低12.83	成交量13.33万
今开13.10	昨收12.99	日振幅2.89%
总市值6.44亿	流通市值3.77亿	总股本4,972万
成交额172.66万	换手率0.46%	流通股本2,907万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KALV","market":"US","secType":"STK","nameCN":"Kalvista Pharmaceuticals Inc","latestPrice":12.96,"timestamp":1745864813578,"preClose":12.99,"halted":0,"volume":133301,"delay":0,"floatShares":29072008,"shares":49715636,"eps":-3.721859,"marketStatus":"交易中","change":-0.03,"latestTime":"04-28 14:26:57 EDT","open":13.1,"high":13.2,"low":12.825,"amount":1726580.669296,"amplitude":0.028868,"askPrice":12.97,"askSize":226,"bidPrice":12.94,"bidSize":250,"shortable":3,"etf":0,"ttmEps":-3.721859,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745870400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1479790800000,"exchange":"NASDAQ","adjPreClose":12.99,"preHourTrading":{"tag":"盘前","latestPrice":13.1,"preClose":12.99,"latestTime":"09:29 EDT","volume":653,"amount":8353.099599000001,"timestamp":1745846998411},"postHourTrading":{"tag":"盘后","latestPrice":12.87,"preClose":12.99,"latestTime":"16:05 EDT","volume":9172,"amount":119123.16,"timestamp":1745611508110},"volumeRatio":0.385059,"impliedVol":0.7192,"impliedVolPercentile":0.42},"requestUrl":"/m/hq/s/KALV","defaultTab":"news","newsList":[{"id":"2529388659","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.00%报12.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529388659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529388659?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:19","pubTimestamp":1745245193,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时19分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.00%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Dogwood Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为1006.46%、695.55%、286.32%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为106.34%、58.81%、43.24%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221953a6c27d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221953a6c27d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2517985069","title":"Kalvista Pharmaceuticals, Inc.盘中异动 大幅拉升5.11%报11.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517985069?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:27","pubTimestamp":1741120066,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时27分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.11%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1330.19%、1258.60%、1224.41%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030504274696399744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030504274696399744&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2516637427","title":"Citizens Capital Markets：重申KalVista Pharma(KALV.US)评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637427","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637427?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:11","pubTimestamp":1741014689,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：重申KalVista Pharma(KALV.US)评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至19.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03231148494584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KALV"],"gpt_icon":0},{"id":"2516148371","title":"Kalvista Pharmaceuticals, Inc.盘中异动 急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516148371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516148371?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:36","pubTimestamp":1740760606,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时36分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.08%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Bioxcel Therapeutics, Inc.、Camp4 Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2922.48%、491.11%、364.17%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、46.60%、43.95%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010036479634359a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010036479634359a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2514542788","title":"Kalvista Pharmaceuticals, Inc.盘中异动 大幅上涨5.06%报11.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514542788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514542788?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:38","pubTimestamp":1740584333,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时38分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.06%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5229.01%、197.73%、185.00%，振幅较大的相关个股有Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为161.02%、43.31%、39.47%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262338539893b7af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262338539893b7af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2513921966","title":"Kalvista Pharmaceuticals, Inc.盘中异动 快速下跌5.45%报10.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513921966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513921966?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:54","pubTimestamp":1740164096,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时54分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.45%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Revolution Medicines Inc C/Wts 17/12/2026 、Invivyd, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为293.98%、247.56%、136.47%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222025456962bb494&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222025456962bb494&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2512485671","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.83%报10.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512485671?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:00","pubTimestamp":1739977248,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时00分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.83%。截至发稿，该股报10.35美元/股，成交量5.089万股，换手率0.10%，振幅5.93%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230048a24c01df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230048a24c01df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2508124256","title":"Kalvista Pharmaceuticals, Inc.盘中异动 大幅拉升5.16%报9.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508124256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508124256?lang=zh_cn&edition=full","pubTime":"2025-02-04 03:11","pubTimestamp":1738609878,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日03时11分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.16%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Invivyd, Inc.、Hcw Biologics Inc.、Gh Research Plc涨幅较大，Cyclerion Therapeutics, Inc.、Hcw Biologics Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为744.10%、723.79%、469.51%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、151.80%、63.94%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204031118987994e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204031118987994e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2508998384","title":"KalVista Pharma(KALV.US)获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508998384","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508998384?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:13","pubTimestamp":1738343582,"startTime":"0","endTime":"0","summary":"KalVista Pharma(KALV.US)获摩根大通证券公司首次覆盖，给予优于大市评级, 目标价19.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/01011347922529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KALV","399975","159848"],"gpt_icon":0},{"id":"2506092873","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.46%报9.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506092873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506092873?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:18","pubTimestamp":1737991132,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时18分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.46%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1741.10%、191.47%、171.32%，振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immatics N V C/Wts 01/07/2025 ，振幅分别为85.35%、65.16%、61.25%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127231852a23174ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127231852a23174ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2505205827","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505205827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505205827?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:15","pubTimestamp":1737476120,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时15分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.18%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。其相关个股中，Channel Therapeutics Corporation、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dogwood Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为755.07%、470.06%、182.16%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001520986e465c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001520986e465c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2504308914","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504308914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504308914?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:54","pubTimestamp":1737042876,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时54分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.03%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Aeon Biopharma, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1777.03%、369.61%、247.72%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为131.33%、104.84%、76.46%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116235436a2247320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116235436a2247320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2503571642","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.95%报7.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503571642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503571642?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951466,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.95%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Eterna Therapeutics Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为183.55%、55.23%、50.88%，振幅较大的相关个股有Vincerx Pharma, Inc.、Onconetix, Inc.、Viracta Therapeutics, Inc.，振幅分别为10.72%、9.31%、9.18%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223106a222fd78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223106a222fd78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2503116589","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.08%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503116589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503116589?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:52","pubTimestamp":1736779956,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时52分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.08%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.42%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4957.92%、3054.99%、406.27%，振幅较大的相关个股有Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.，振幅分别为118.35%、104.79%、92.90%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132252379602575b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132252379602575b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2502815829","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502815829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502815829?lang=zh_cn&edition=full","pubTime":"2025-01-11 02:46","pubTimestamp":1736534785,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日02时46分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.22%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.98%。其相关个股中，Conduit Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Omniab Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1247.58%、853.06%、234.82%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.20%、100.85%、64.55%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111024625aba63aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111024625aba63aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2502138705","title":"Kalvista Pharmaceuticals, Inc.盘中异动 快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502138705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502138705?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:45","pubTimestamp":1736358341,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时45分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.02%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3455.17%、600.25%、589.11%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、143.11%、89.00%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109014541aba3763a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109014541aba3763a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2500397161","title":"Kalvista Pharmaceuticals, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500397161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500397161?lang=zh_cn&edition=full","pubTime":"2025-01-03 00:38","pubTimestamp":1735835936,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日00时38分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.08%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Revelation Biosciences Inc C/Wts 10/01/2027 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Celularity Inc C/Wts 16/07/2026 涨幅较大，Revelation Biosciences, Inc.、Mustang Bio, Inc.、知临集团较为活跃，换手率分别为1172.02%、253.63%、194.35%，振幅较大的相关个股有Mustang Bio, Inc.、Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为146.61%、127.98%、125.71%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103003856ab9c13fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103003856ab9c13fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2493718100","title":"Kalvista Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493718100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493718100?lang=zh_cn&edition=full","pubTime":"2024-12-24 04:40","pubTimestamp":1734986428,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日04时40分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.20%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Sol-Gel Technologies Ltd.、Traws Pharma, Inc.、Rapt Therapeutics, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Traws Pharma, Inc.、Gt Biopharma, Inc.较为活跃，换手率分别为1029.80%、919.77%、918.30%，振幅较大的相关个股有Sol-Gel Technologies Ltd.、Traws Pharma, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为229.60%、157.37%、148.33%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224044029984d3f94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224044029984d3f94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2493426032","title":"Kalvista Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.07%报8.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493426032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493426032?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:51","pubTimestamp":1734713482,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时51分，Kalvista Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.07%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Abpro Holdings, Inc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2543.56%、413.96%、98.23%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.，振幅分别为173.15%、155.76%、105.11%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100512295ea9eba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100512295ea9eba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2489231274","title":"Kalvista Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489231274?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:06","pubTimestamp":1733497593,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时06分，Kalvista Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.14%。Kalvista Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Cervomed Inc.、Adc Therapeutics Sa涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为46.44%、34.43%、23.09%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、Cyclerion Therapeutics, Inc.，振幅分别为27.68%、24.33%、19.74%。Kalvista Pharmaceuticals, Inc.公司简介：KalVista Pharmaceuticals Inc 是一家专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230633ab62e7e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230633ab62e7e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KALV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kalvista.com","stockEarnings":[{"period":"1week","weight":0.0825},{"period":"1month","weight":0.0762},{"period":"3month","weight":0.5087},{"period":"6month","weight":0.1122},{"period":"1year","weight":0.2383},{"period":"ytd","weight":0.5336}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"KalVista Pharmaceuticals, Inc.于2004年3月26日在特拉华州注册成立。该公司是一家临床阶段制药公司，专注于发现、开发和商业化小分子蛋白酶抑制剂，用于有重大未满足需求的疾病。该公司运用他们对蛋白酶的化学和生物学的洞见，开发出具有高选择性、效力和生物利用度的口服疗法，该公司相信这将使它们成为治疗疾病的成功药物。该公司利用这些能力开发了针对遗传性血管性水肿（HAE）的新型小分子血浆激肽释放酶抑制剂。该公司还在进行一项新的口服XIIa因子（“XIIa因子”）抑制剂项目的临床前开发。该公司正在初步推进这一项目，以提供下一代HAE疗法，这也为将来扩展到其他未满足的高需求适应症提供了机会。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.015737},{"month":2,"riseRate":0.555556,"avgChangeRate":0.181118},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.059731},{"month":4,"riseRate":0.444444,"avgChangeRate":0.022989},{"month":5,"riseRate":0.5,"avgChangeRate":-0.027585},{"month":6,"riseRate":0.625,"avgChangeRate":-0.000971},{"month":7,"riseRate":0.5,"avgChangeRate":0.018821},{"month":8,"riseRate":0.625,"avgChangeRate":0.169598},{"month":9,"riseRate":0.25,"avgChangeRate":-0.062258},{"month":10,"riseRate":0.375,"avgChangeRate":0.021922},{"month":11,"riseRate":0.5,"avgChangeRate":0.04349},{"month":12,"riseRate":0.444444,"avgChangeRate":0.041429}],"exchange":"NASDAQ","name":"Kalvista Pharmaceuticals Inc","nameEN":"Kalvista Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kalvista Pharmaceuticals Inc(KALV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kalvista Pharmaceuticals Inc,KALV,Kalvista Pharmaceuticals Inc股票,Kalvista Pharmaceuticals Inc股票老虎,Kalvista Pharmaceuticals Inc股票老虎国际,Kalvista Pharmaceuticals Inc行情,Kalvista Pharmaceuticals Inc股票行情,Kalvista Pharmaceuticals Inc股价,Kalvista Pharmaceuticals Inc股市,Kalvista Pharmaceuticals Inc股票价格,Kalvista Pharmaceuticals Inc股票交易,Kalvista Pharmaceuticals Inc股票购买,Kalvista Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kalvista Pharmaceuticals Inc(KALV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况